The US drug regulator had conducted a routine current Good Manufacturing Practices (cGMP) inspection at the said facility between November 7 to November 13, 2024.
Your email address will not be published. Required fields are marked *
Name*
Email*
Website
Save my name, email, and website in this browser for the next time I comment.